Join us for a symposium on metabolic dysfunction-associated steatohepatitis (MASH) designed to encourage the exchange of ideas between leaders in the field and attendees.
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.
Have increased knowledge regarding the: Data for new and emerging treatments for MASH Mechanisms of action for emerging MASH therapies in relation to MASH pathophysiology Similarities and differences of endpoints for clinical trials for emerging MASH therapies